Life Technologies | Kostnadene For Salg



Cost Of Sales Endring Dato
Ardelyx USD 18.26M 2.54M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Cipla INR 22.64B 189.3M 2024-12
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 675K 2.93M 2024-12
CSL USD 3.41B 315M 2024-06
Galapagos EUR 13.73M 99.2M 2025-03
GlaxoSmithKline GBP 2.56B 162M 2024-12
Grifols EUR 1.21B 143.12M 2024-12
Life Technologies 0 0 2024-09
Novartis USD 3.32B 90M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
United Therapeutics USD 75.9M 7.2M 2024-12



Life Technologies Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.